Post by PressRelease on Jun 18, 2024 10:36am
New Press Release - GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report
Comment by
lscfa on Jun 18, 2024 1:00pm
Pg. 26 - peptide column is new and it shows GPM has more benefits
Comment by
lscfa on Jun 18, 2024 6:11pm
Stonegate issues research reports with financial anaylsis and price targets for other co.s....Sirona mgmt won't offer any damn visibility on revenues or earnings so Stonegate had to do a industry view piece. e.g. https://stonegateinc.com/download/stgo-q1-24/?wpdmdl=863&refresh=6663039f0c1c81717765023 https://www.newsfilecorp.com/company/7294/Reportable-Inc.
Comment by
lscfa on Jun 18, 2024 6:14pm
example of Stonegate report on pre-revenue co...... https://stonegateinc.com/download/burcon-initiation/?wpdmdl=812&refresh=6630eb784e3821714482040
Comment by
Fruckedagain on Jun 18, 2024 7:37pm
There are none. and for years the science has been proven over and over again as non commercial. Look at how many supposed companys looked at it. Of course we can't verify it a all it has been done it secrecy because..well because.
Comment by
lscfa on Jun 20, 2024 1:13am
Why the hell didn't Stonegate do a share price valuation based on Sirona's financial forecast? (See image). Did mgmt even share this info with Stonegate?
Comment by
forhandlaren on Jun 20, 2024 10:26am
This informal slide was excempted in the official Investor Presentation. Not sure why. Have you asked them now?